How to Exercise Safely with Asthma: Practical Plans, Medications, and Training Strategies That Work

Table of Contents

1. Key Highlights
2. Introduction
3. How Exercise Narrows Airways: The Physiology Behind EIB
4. Recognizing and Diagnosing Exercise-Induced Bronchoconstriction
5. Medical Strategies: Medications That Prevent and Treat EIB
6. Nonpharmacologic Strategies: Training, Warm-ups, and Environmental Controls
7. Tailoring Activity Choices: Sports and Exercises That Fit Asthma Profiles
8. Children, Adolescents, and School Sports: Practical Guidance for Parents and Coaches
9. Emergency Preparedness: Recognizing and Responding to Severe Episodes
10. Building a Long-Term Exercise Plan: Progression, Monitoring, and Adjustments
11. Medication Stewardship: Avoiding Overreliance and Managing Tolerance
12. Special Topics: Swimming, Cold-Weather Sports, and Elite Athletes
13. Evidence Snapshot: What Research Shows About Exercise and Asthma
14. Practical Tools: Checklists, Sample Action Plans, and Workout Templates
15. Barriers and Solutions: Addressing Compliance, Anxiety, and Access
16. Real-World Case Studies
17. Monitoring Progress: When to Reassess and How to Interpret Trends
18. Resources and Support
19. FAQ

Key Highlights

• Exercise-induced bronchoconstriction (EIB) affects people with and without chronic asthma; effective management includes pre-exercise medication, targeted warm-ups, and environmental controls.
• A structured approach—medical evaluation, an individualized action plan, gradual training progression, and clear emergency steps—lets most people with asthma train safely and improve fitness and lung resilience.

Introduction

Shortness of breath during exercise can be terrifying. For people whose airways tighten with exertion, running up a flight of stairs or joining a team sport may feel like stepping into danger. Yet restriction is not the only outcome. With accurate assessment, the right mix of medication and technique, and predictable safeguards, most people with asthma can exercise well and reap measurable health benefits.

The key lies in precision: knowing whether bronchoconstriction follows exercise, identifying what provokes symptoms, and matching training and treatment to the individual. This article explains how exercise triggers airway narrowing, how clinicians diagnose and quantify exercise-induced bronchoconstriction, which medications and nonpharmacologic measures work best, and how athletes, parents, and recreational exercisers can design safe, effective programs. Practical examples and clear emergency steps help translate clinical guidance into everyday practice.

How Exercise Narrows Airways: The Physiology Behind EIB

Breathing faster and deeper changes the properties of the air reaching the small bronchioles. During sustained hard exercise, inhaled air tends to be colder and drier, even when ambient conditions feel warm. The combination of increased ventilation and evaporative water loss from the airway lining provokes osmotic and thermal stress. Mast cells and other inflammatory cells react, releasing mediators such as histamine and leukotrienes that cause smooth muscle contraction and mucus production. The result: bronchoconstriction, the characteristic wheeze, cough, chest tightness, and shortened breath.

Not every person with asthma experiences EIB. Conversely, people without a chronic asthma diagnosis can have EIB as an isolated phenomenon. Elite endurance athletes, especially those exposed to cold dry air or chlorinated pools, show higher rates of airway hyperresponsiveness. The variability highlights the need to test and treat individuals rather than assume an outcome based on diagnosis alone.

Physiologic hallmarks

• Rapid breathing increases heat and water loss from airway surfaces.
• Osmotic changes stimulate mediator release from inflammatory and structural airway cells.
• Smooth muscle constriction and increased secretions reduce airway caliber.
• Symptoms typically occur during exercise or in the first 10–20 minutes after stopping, though delayed responses can happen.

Understanding these mechanisms clarifies why certain environments and activities carry greater risk, and why specific interventions—humid environments, pre-exercise bronchodilators, and warm-ups—are effective.

Recognizing and Diagnosing Exercise-Induced Bronchoconstriction

Symptoms alone are an unreliable guide. Wheeze, cough, and breathlessness during activity can stem from poor conditioning, vocal cord dysfunction, cardiovascular limitations, or deconditioning, not only airway narrowing. Objective assessment distinguishes EIB from other causes and measures severity.

Clinical history A careful history should establish timing and pattern of symptoms: onset during exercise or in the recovery period, triggers (cold air, chlorine, pollen, pollution), reproducibility, and response to bronchodilators. Track frequency of rescue inhaler use: frequent short-acting beta-agonist (SABA) use signals poor control.

Objective testing Pulmonary function testing and provocation tests confirm EIB and quantify airway responsiveness.

• Spirometry with bronchodilator testing measures baseline airway obstruction but can be normal between episodes. A 10–15% or greater fall in FEV1 after exercise is commonly used to define EIB. Exact thresholds vary across guidelines; clinicians interpret results in the clinical context.
• Exercise challenge tests on a treadmill or cycle ergometer replicate typical exertion and record pre- and post-exercise FEV1 values.
• Eucapnic voluntary hyperpnea (EVH) is the preferred laboratory test for athletes because it simulates high ventilation rates. It identifies athletes whose routine training provokes bronchoconstriction.
• Methacholine or histamine challenge tests assess nonspecific bronchial hyperresponsiveness but are less specific for exercise-related responses.
• Fractional exhaled nitric oxide (FeNO) and induced sputum eosinophil counts provide insight into airway inflammation and help guide anti-inflammatory therapy.

Peak flow monitoring A portable peak flow meter is useful for day-to-day monitoring. Measure baseline values and compare post-exercise readings. A significant drop from personal best peak flow indicates bronchoconstriction and the need to follow an action plan.

Practical triage If symptoms are mild and predictable, start with a pragmatic assessment: trial of pre-exercise SABA and use of an action plan. If symptoms persist despite this or if activities demand high-level performance (competitive athletes), refer for formal testing.

Medical Strategies: Medications That Prevent and Treat EIB

Medication choice depends on whether the pattern reflects isolated EIB or poorly controlled chronic asthma. Pharmacologic options reduce airway inflammation, block bronchoconstricting mediators, or directly relax airway smooth muscle.

Short-acting bronchodilators (SABA)

• Salbutamol/albuterol (2 puffs, typically 100–200 mcg per puff) taken 10–15 minutes before exercise provides rapid airway relief and effective short-term protection for most people.
• SABAs last several hours and offer a simple pre-exercise prophylaxis. Relying on high-frequency SABA use to manage daily symptoms indicates inadequate control and requires reassessment.

Long-acting beta-agonists (LABA)

• LABAs provide extended bronchodilation but must not be used as monotherapy in asthma. When combined with inhaled corticosteroids (ICS), they offer improved control and can reduce EIB frequency.
• Tolerance to beta-agonists can develop after daily use. Using SALA/LABA intermittently before exercise reduces this concern.

Inhaled corticosteroids (ICS)

• ICS are the cornerstone for controlling airway inflammation. Regular ICS therapy reduces baseline airway hyperresponsiveness and decreases the severity and frequency of EIB.
• For many with frequent exercise symptoms, starting or optimizing ICS therapy improves exercise tolerance over weeks to months.

Leukotriene receptor antagonists (LTRAs)

• Oral montelukast can reduce EIB frequency and has particular benefit for people with allergic triggers or aspirin-exacerbated respiratory disease. It is an option when inhaled treatment cannot be used or as an adjunct.

Mast cell stabilizers

• Cromolyn sodium nebulizers or inhalers taken before exercise can blunt mediator release and prevent bronchoconstriction. Their use has diminished with newer agents but remains an option, particularly in children or those preferring non-steroidal approaches.

Anticholinergics

• Short-acting antimuscarinics have a role in acute relief. Long-acting muscarinic antagonists (LAMA) combined with ICS/LABA are primarily indicated in severe disease or specific phenotypes.

Oral corticosteroids

• Reserved for severe exacerbations or difficult-to-control asthma despite optimized inhaled therapy. Prolonged oral steroid use carries systemic risks and requires specialist oversight.

Practical medication plan

• Carry a fast-acting rescue inhaler at all times during exercise sessions.
• Use pre-exercise SABA as needed for predictable EIB.
• If rescue inhaler use increases or daily symptoms occur, schedule a prompt review; escalate controller treatment as indicated.
• Consider adding montelukast or cromolyn in specific cases after discussing benefits and side effects.

Medication considerations for athletes Competitive athletes should consult team physicians about anti-doping regulations. Inhaled beta-2 agonists are generally permitted within dose limits; some preparations require notification or a therapeutic use exemption. Team medical staff can handle regulatory paperwork.

Nonpharmacologic Strategies: Training, Warm-ups, and Environmental Controls

Medication is central, but daily training practices shape outcomes. Changes to environment, exercise type, and warm-up routines reduce risk and improve consistency.

Warm-up and the refractory period A progressive 10–15 minute warm-up that alternates moderate and brief high-intensity bursts can induce a transient refractory period, reducing the chance of bronchoconstriction during subsequent exercise. The mechanism likely involves partial mast cell mediator depletion. Cool-down should be gradual to avoid late-onset bronchospasm.

Training formats

• Interval training with short, intense bursts interspersed by recovery periods tends to provoke fewer EIB episodes than continuous sustained high-intensity exercise for many individuals.
• Strength training and brief anaerobic efforts (sprinting, power lifts) provoke fewer symptoms than long-distance running or prolonged aerobic sessions.

Environment and timing

• Cold, dry air and outdoor pollution increase EIB risk. Schedule workouts during milder temperatures and when pollen counts or pollution levels are low.
• Indoor swimming pools offer warm, humid air—often better tolerated—but strong chlorination and by-products can irritate some airways. Balance the benefits of humidity with potential irritants.
• Wear a scarf or heat-exchange mask during cold-weather exercise. These devices warm and humidify inhaled air and reduce evaporative losses.
• On high-pollen or poor air-quality days, move training indoors or select lower-intensity workouts.

Hydration, nutrition, and rest

• Adequate hydration keeps airway secretions less viscous and supports mucociliary clearance.
• Avoid heavy meals immediately before vigorous exercise if reflux or vocal cord dysfunction worsens symptoms.
• Treating comorbidities—rhinosinusitis, allergic rhinitis, gastroesophageal reflux disease—reduces airway irritation and improves exercise tolerance.

Breathing techniques and respiratory muscle training

• Diaphragmatic breathing, nasal breathing where feasible, and pursed-lip breathing assist control but do not replace medical therapy.
• Inspiratory muscle training with threshold devices can enhance respiratory muscle endurance and may reduce perceived breathlessness in some people. Evidence shows modest improvements; use under supervision for best results.

Technology and monitoring

• Peak flow meters and portable spirometers track function around workouts.
• Smart inhalers record usage patterns and identify worsening control early.
• Wearable devices that monitor heart rate and exertion can help titrate intensity to safer levels.

Tailoring Activity Choices: Sports and Exercises That Fit Asthma Profiles

Choosing the right sport matters. Consider the typical ventilatory demand, environmental exposure, and predictability of exertion.

Lower-risk options

• Swimming: Warm, humid air reduces airway drying. Many people with asthma find swimming the most tolerable aerobic exercise. Caveat: some swimmers develop airway symptoms linked to pool chemicals; ensure pools are well-ventilated and chlorination by-products minimized.
• Strength training and resistance workouts: Short bursts of effort with rest periods reduce continuous high ventilation.
• Team sports with intermittent play (soccer, basketball): These can be well tolerated if intensity is managed and SABA is used before play.
• Yoga, Pilates: Improve flexibility, core control, and breathing technique and often reduce breathlessness.

Higher-risk activities

• Cross-country skiing, speed skating, and long-distance running: Cold dry air and prolonged high ventilation increase EIB risk.
• Ice hockey and other sports on cold rinks expose athletes to low temperatures and air contaminants.
• Endurance competitions (marathons, long triathlons) demand prolonged high ventilation and have a higher prevalence of EIB among participants.

Practical selection

• Beginners and those with newly diagnosed symptoms should favor controlled environments and lower-risk activities while being assessed.
• Competitive athletes in high-risk sports benefit from specialized testing (EVH), tailored pharmacologic prophylaxis, and regular monitoring.

Real-world illustration Michael Phelps, an Olympic swimmer with childhood asthma, trained in warm, humid pool air and used medications as needed. His example underscores that asthma does not preclude elite performance when management is precise and integrated with training.

Children, Adolescents, and School Sports: Practical Guidance for Parents and Coaches

Physical activity is essential for children’s physical and psychosocial development, and asthma should not be a barrier. Proper preparation keeps kids active and safe.

School and team participation

• Ensure a written asthma action plan is on file with coaches and school nurses. The plan should detail rescue medication dosages, expected symptoms, and emergency contacts.
• Children should carry or have prompt access to a rescue inhaler. Spacer devices improve delivery in younger children.
• Coaches should receive basic training to recognize asthma symptoms and administer emergency inhaler doses or call for medical help.

Medication timing

• Pre-exercise SABA 10–15 minutes before activity prevents many episodes in children.
• Monitor medication use; increasing rescue inhaler frequency or missed nights of sleep due to cough or wheeze indicate poor control and require medical review.

Psychological aspects

• Address fear of exertion. Children who experience breathlessness may avoid activity and fall behind peers. Reassurance, graduated exposure to activity, and success during supervised sessions build confidence.

School accommodations

• Allow brief rest breaks and timely access to medication.
• Avoid excluding children from physical education unless uncontrolled symptoms pose a real risk. Modify exertion rather than removing participation completely.

Case example A middle-school soccer player with intermittent post-exercise wheeze improved after a trial of pre-exercise albuterol, incorporation of a structured warm-up, and daily intranasal therapy for allergic rhinitis. Her playing time increased and she reported fewer absences.

Emergency Preparedness: Recognizing and Responding to Severe Episodes

Even with best practices, acute bronchospasm can occur. A clear, rehearsed emergency plan saves lives.

Recognizing danger signs

• Inability to speak in full sentences, rapid breathing, cyanosis, severe chest retractions, confusion, or drowsiness signal a medical emergency.
• Failure to respond to two rounds of quick-relief inhaler (after 10–15 minutes) requires urgent medical attention.

Stepwise response to an acute episode during exercise

1. Stop activity and sit upright to maximize airflow.
2. Use two to four puffs of a SABA via inhaler (use spacer if available). If using a nebulizer, follow prescribed dosing.
3. Wait 5–10 minutes. If symptoms substantially improve, repeat inhaler use if prescribed and monitor closely.
4. If symptoms do not improve or worsen, call emergency services immediately.
5. If the person becomes exhausted or has severe respiratory distress, administer emergency care per local guidelines and seek urgent transport.

Preparedness checklist for training sessions and teams

• At least one functioning rescue inhaler should be on-site; ideally, athletes carry personal medication.
• Coaches and trainers should know members’ action plans and local emergency procedures.
• Automated external defibrillators (AEDs) and first-aid supplies should be available at high-level events.
• Emergency drills increase readiness and reduce response time.

Building a Long-Term Exercise Plan: Progression, Monitoring, and Adjustments

Sustained improvements require planning and periodic reassessment.

Initial phase (first 4–8 weeks)

• Start with low to moderate intensity for short durations. Focus on technique, controlled breathing, and a robust warm-up and cool-down.
• Keep a symptom and medication diary to detect patterns: times of day, environments, and types of exertion that provoke symptoms.

Progression phase (8–12 weeks)

• Incrementally increase duration and intensity by no more than 10% per week.
• Integrate interval sessions to build tolerance while minimizing prolonged high ventilation.
• Reassess pulmonary function every few months if symptoms persist or if training load increases.

Maintenance phase

• Maintain a regular schedule with at least 3 sessions per week. Consistency reduces day-to-day variability and improves cardiorespiratory fitness.
• Continue monitoring rescue inhaler use. A downward trend in SABA reliance indicates improving control.

When to return to the clinician

• Increased rescue inhaler use.
• Night-time symptoms or waking with cough or shortness of breath.
• Reduced exercise tolerance despite adherence to preventive measures.
• Consider referral to a pulmonologist or allergist for specialist testing and therapy adjustments.

Case pathway A recreational runner with mild EIB completed a 12-week plan: pre-exercise SABA, progressive interval training, and attention to pollen counts. Her race times improved, rescue inhaler use dropped by half, and her physician reduced controller medication after objective testing confirmed improved airway stability.

Medication Stewardship: Avoiding Overreliance and Managing Tolerance

Short-acting bronchodilators are effective, but overuse signals a problem and can lead to diminished benefit.

Recognizing tolerance

• Daily frequent need for SABA suggests inadequate baseline control.
• Diminished bronchodilator response after regular pre-exercise use may require switching strategies.

Approach

• Optimize inhaled corticosteroid dose before increasing bronchodilator frequency.
• Combine LABA with ICS rather than using LABA alone.
• Consider adding or substituting anti-inflammatory or leukotriene-directed therapy based on symptoms and testing.

Smart inhaler technology Device-based adherence tracking reveals patterns of overuse, missed controller doses, and response times. Clinicians can adjust therapy based on data rather than recall alone.

Special Topics: Swimming, Cold-Weather Sports, and Elite Athletes

Swimming

• Warm humid conditions favor the airways but pool chemicals can irritate. Choose well-ventilated facilities and avoid excessive pool chlorination by-products.
• Elite swimmers may still develop airway inflammation from chronic exposure; regular monitoring is prudent.

Cold-air sports

• Cross-country skiers and winter athletes face particularly high EIB prevalence due to cold dry inhalation. Heat-exchange masks, pre-exercise bronchodilators, and careful conditioning reduce risk.

Elite athletes and anti-doping

• Many top athletes have asthma and perform at elite levels with careful management.
• Regulatory considerations: inhaled beta-2 agonists are permitted within specific dosage limits and may require declaration or exemption at major events. Team physicians handle paperwork and monitoring.

Performance considerations

• When asthma is controlled, VO2 max and endurance can approach non-asthmatic peers. Untreated or poorly controlled asthma reduces peak performance and increases injury risk from over-exertion and poor recovery.

Evidence Snapshot: What Research Shows About Exercise and Asthma

Clinical trials and observational studies indicate:

• Regular aerobic exercise improves cardiorespiratory fitness and quality of life in people with asthma.
• Structured exercise training reduces symptoms and may improve FEV1 modestly when combined with optimized medication.
• Warm-up protocols produce a measurable refractory period that reduces EIB during subsequent effort.
• Montelukast and inhaled corticosteroids reduce the frequency and severity of EIB episodes.
• Inspiratory muscle training shows small-to-moderate benefits in breathlessness and exercise capacity for selected patients.

These findings support combined pharmacologic and behavioral strategies rather than reliance on a single approach.

Practical Tools: Checklists, Sample Action Plans, and Workout Templates

Starter checklist before exercise

• Carry prescribed rescue inhaler and spacer if needed.
• Use pre-exercise SABA when recommended.
• Complete 10–15 minute warm-up with alternating intensity.
• Check local pollen and air quality indices.
• Wear a scarf or mask in cold weather.
• Stay hydrated and avoid heavy meals just before training.

Sample acute action plan for exercise-induced symptoms

• Mild-mod symptoms (wheeze, cough, chest tightness): Stop, 2–4 puffs of SABA, rest, monitor. Repeat inhaler after 5–10 minutes if needed. Resume only if symptoms resolve and breathing returns to baseline.
• Severe symptoms (inability to speak, severe breathlessness, cyanosis): Call emergency services. Administer SABA while awaiting help. Use emergency inhaler/nebulizer per protocol.

Sample 8-week beginner workout template for someone with mild EIB Weeks 1–2: 3 sessions/week; 20–25 minutes. Warm-up 10 minutes (walk to jog intervals), 10 minutes of low-moderate continuous activity, cool-down 5 minutes. Pre-exercise SABA as prescribed. Weeks 3–4: 3–4 sessions/week; 25–30 minutes. Warm-up 12 minutes with 2 × 30-second higher-intensity efforts; main set: 15 minutes alternating 3 minutes moderate/1 minute easy. Weeks 5–8: 4 sessions/week; 30–40 minutes. Include one longer moderate session (up to 40 minutes), one interval session (6–8 × 2 minutes high/2 minutes low), two strength/mobility sessions.

Adjust intensity based on symptoms and peak flow readings.

Barriers and Solutions: Addressing Compliance, Anxiety, and Access

Many people avoid exercise out of fear of symptoms. Addressing practical and psychological barriers increases adherence.

Fear and avoidance

• Start with supervised sessions and visible success milestones.
• Provide education on safe practices and signs that indicate worsening control.
• Involve coaches and family to create supportive environments.

Medication access and cost

• Generic inhalers, insurance assistance programs, and community health resources improve access. Clinicians should discuss affordable options without compromising control.

Adherence and follow-up

• Use reminders, smart inhaler data, and scheduled reviews to maintain controller therapy.
• Regular reassessment prevents gradual decline in control that leads to exercise intolerance.

Real-World Case Studies

Case 1: Recreational runner with new-onset EIB A 34-year-old amateur runner experiences coughing and chest tightness after 20–30 minutes of running. Spirometry is normal at rest. An exercise challenge demonstrates a 15% fall in FEV1 post-exercise. He began pre-exercise albuterol, added a 10–15 minute warm-up with intermittent sprints, and shifted two sessions indoors during high-pollen days. Over 3 months his weekly mileage increased without symptoms and race times improved.

Case 2: High school soccer player with nocturnal cough A 15-year-old with nighttime cough and exertional wheeze had uncontrolled allergic rhinitis. Starting intranasal steroids, daily ICS, and pre-exercise SABA allowed continued play. The coach kept an extra inhaler pool and learned the action plan. Absences fell and performance stabilized.

Case 3: Elite cross-country skier A national-level skier tested positive for marked EIB on EVH. Team physicians instituted inhaled corticosteroid/LABA combination therapy, scheduled daytime training to avoid peak pollution, and used heat-exchange masks. Monitoring and periodic re-testing allowed sustained competition without performance detriment.

Monitoring Progress: When to Reassess and How to Interpret Trends

Regular objective reassessment prevents surprises.

When to reassess

• After therapy changes, every 3–6 months until stable.
• When exercise goals increase or competitive demands change.
• If rescue inhaler use increases or night symptoms appear.

Interpreting trends

• Declining rescue inhaler use, rising peak flow and improved exercise tolerance indicate improving control.
• Increasing symptoms or rescue use suggests need for treatment escalation, comorbidity review, or specialist referral.

Resources and Support

Useful resources typically include national asthma foundations, patient advocacy groups, and sports medicine services. Team physicians, school nurses, and local pulmonary clinics provide individualized support.

FAQ

Q: Can everyone with asthma exercise safely? A: Most people with asthma can exercise safely. The safe path begins with evaluation and an individualized plan that includes medication management, warm-up routines, and environmental strategies. People with severe or poorly controlled asthma require closer medical oversight before sustained high-intensity training.

Q: How effective are pre-exercise inhalers? A: Short-acting beta-agonists taken 10–15 minutes before exertion prevent or reduce EIB in the majority of cases. Their efficacy lasts several hours. Increased reliance on these inhalers for daily control signals a need to reassess baseline anti-inflammatory therapy.

Q: Is swimming always safe for people with asthma? A: Many benefit from swimming because of warm, humid air. However, some people are sensitive to chlorine by-products. Pool ventilation and maintenance matter. If symptoms persist despite swimming in a well-kept pool, consult a clinician.

Q: What’s the diagnostic threshold for EIB? A: A decline in FEV1 after exercise of approximately 10–15% from baseline is commonly used to define EIB. Exact cutoffs vary, and clinicians interpret tests alongside symptoms and context.

Q: Can children with asthma participate in competitive sports? A: Yes. With appropriate monitoring, medication access, and an action plan, many children compete successfully. Team medical staff and parents should coordinate to ensure safety and compliance with any sport-specific medication declarations.

Q: Are there non-medication strategies that really help? A: Yes. Structured warm-ups that include intermittent high-intensity efforts, gradual cool-downs, hydrating, breathing techniques, heat-exchange masks for cold weather, and selecting lower-risk activities all reduce symptom frequency and severity.

Q: When should I seek urgent medical care? A: Seek emergency help if shortness of breath is severe, you cannot speak in full sentences, symptoms do not improve after two rounds of quick-relief inhaler, or there are signs of low oxygenation (cyanosis, confusion).

Q: Can asthma medications affect athletic eligibility? A: Inhaled medications are generally allowed, but competitive athletes should consult team physicians about therapeutic use exemptions and permitted dose limits for certain beta-2 agonists. Team medical staff usually manages compliance.

Q: Will exercise make my asthma worse long-term? A: Regular exercise, combined with appropriate treatment, generally improves overall health and lung function. Uncontrolled asthma, however, increases risk during exertion. With proper control, exercise contributes positively to long-term outcomes.

Q: What if I still have symptoms despite following recommendations? A: Consult your clinician for a reassessment. Options include optimizing inhaled corticosteroid doses, adding leukotriene modifiers or mast cell stabilizers, specialized testing (EVH or methacholine challenge), or assessing comorbidities such as reflux, rhinosinusitis, or vocal cord dysfunction.

Asthma should inform how you prepare for activity, not dictate whether you participate. With accurate diagnosis, a clear medication strategy, tailored training, and predictable emergency steps, exercise becomes an instrument for improvement rather than a threat.